Terug
Dagbereik
€ 71,94
€ 74,49
52-Weeksbereik
€ 6,45
€ 77,00
Volume
698.521
50D / 200D Gem.
€ 56,05
/
€ 44,68
Vorige Slotkoers
€ 72,22
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -9,2 | 0,4 |
| P/B | 16,8 | 2,9 |
| ROE % | -217,9 | 3,8 |
| Net Margin % | -297,1 | 3,9 |
| Rev Growth 5Y % | -14,2 | 10,0 |
| D/E | 1,7 | 0,2 |
Koersdoel Analisten
Hold
€ 136,40
+83.5%
Low: € 105,00
High: € 165,00
Forward WPA
-€ 10,10
Omzet Sch.
41 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
-€ 10,44
-€ 12,84 – -€ 3,55
|
210 M | 6 |
| FY2029 |
-€ 12,81
-€ 15,75 – -€ 4,35
|
110 M | 6 |
| FY2028 |
-€ 12,96
-€ 19,89 – -€ 9,78
|
54 M | 8 |
Belangrijkste Punten
Revenue declined -14,20% annually over 5 years
Negative free cash flow of -208,68M
Revenue growth is decelerating — 1Y growth trails 5Y average by 29,69%
Capital efficient — spends only 0,31% of revenue on capex
Groei
Revenue Growth (5Y)
-14,20%
Revenue (1Y)-43,89%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-217,94%
ROIC-41,08%
Net Margin-297,07%
Op. Margin-236,77%
Veiligheid
Debt / Equity
1,66
Current Ratio4,97
Interest Coverage-4,99
Waardering
P/E Ratio
-9,20
P/B Ratio16,80
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -43,89% | Revenue Growth (3Y) | -21,71% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -14,20% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 55,23M | Net Income (TTM) | -164,08M |
| ROE | -217,94% | ROA | -58,51% |
| Gross Margin | 100,00% | Operating Margin | -236,77% |
| Net Margin | -297,07% | Free Cash Flow (TTM) | -208,68M |
| ROIC | -41,08% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,66 | Current Ratio | 4,97 |
| Interest Coverage | -4,99 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -9,20 | P/B Ratio | 16,80 |
| P/S Ratio | 27,32 | PEG Ratio | -0,36 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,51B | Enterprise Value | 1,64B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 55,23M | 98,43M | 90,12M | 92,06M | 101,91M |
| Net Income | -164,08M | -118,96M | -276,06M | -368,20M | -523,84M |
| EPS (Diluted) | -9,73 | -8,68 | -21,79 | -29,51 | -42,90 |
| Gross Profit | 55,23M | 67,74M | 53,48M | 70,42M | 77,01M |
| Operating Income | -130,77M | -105,20M | -137,43M | -240,24M | -446,10M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 280,41M | 303,85M | 398,03M | 710,60M | 1,12B |
| Total Liabilities | 190,57M | 243,11M | 267,05M | 343,96M | 437,68M |
| Shareholders' Equity | 89,83M | 60,74M | 130,99M | 366,64M | 679,51M |
| Total Debt | 148,91M | 102,56M | 117,78M | 131,50M | 143,18M |
| Cash & Equivalents | 15,12M | 44,25M | 35,28M | 88,23M | 25,22M |
| Current Assets | 266,27M | 261,29M | 330,70M | 545,97M | 795,58M |
| Current Liabilities | 53,54M | 61,40M | 51,27M | 68,20M | 85,20M |